at its catalytic core, processes the amyloid precursor protein (APP) producing Ab peptides, the structural components of the amyloid fibers found in amyloid plaques (AP) and cerebrovascular that g-secretase substrate processing is regulated by proteins termed g-secretase substrate recruiting factors (gSSRFs) that bridge substrates to g-secretase complexes. These factors constitute novel targets for pharmacological control of specific g-secretase products, such as Ab and signaling peptides. PS familial Alzheimer's disease (FAD) mutants cause a loss of g-secretase cleavage function at epsilon sites of substrates thus inhibiting production of cell signaling peptides while promoting accumulation of uncleaved toxic substrates. Importantly, g-secretase inhibitors may cause toxicity in vivo by similar mechanisms. Here we review novel mechanisms that control g-secretase substrate selection and cleavage and examine their relevance to AD. ß 2012 Elsevier Ltd. All rights reserved.
